Estrogen replacement enhances acquisition of a spatial memory task and reduces deficits associated with hippocampal muscarinic receptor inhibition

Hormones and Behavior

Volumn 36, Issue 3, 1999, Pages 222-233

  Gibbs, Robert B ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Alzheimer's disease; Basal forebrain; Cholinergic; Cognition; Delayed matching to position; GABAergic; Hormone replacement therapy; T maze

Indexed keywords

ESTRADIOL; ESTROGEN; MUSCARINIC RECEPTOR; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; FOREBRAIN; GABAERGIC SYSTEM; HIPPOCAMPUS; LEARNING; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

EID: 0033385115     PISSN: 0018506X     EISSN: None     Source Type: Journal    
DOI: 10.1006/hbeh.1999.1541     Document Type: Article

References (43)

1. Baldereschi M., Di Carlo A., Lepore V., Bracco L., Maggi S., Grigoletto F., Scarlato G., Amaducci L. Estrogen-replacement therapy and Alzheimer's disease in the Italian Longitudinal Study on Aging. Neurology. 50:1998;996-1002.
2. Bimonte H. A., Denenberg V. H. Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology. 24:1999;161-173.
3. Blokland A. Acetylcholine: A neurotransmitter for learning and memory. Brain Res. Rev. 21:1996;285-300.
4. Daniel J. M., Fader A. J., Spencer A. L., Dohanich G. P. Estrogen enhances performance of female rats during acquisition of a radial arm maze. Horm. Behav. 32:1998;217-225.
5. Fader A. J., Hendricson A. W., Dohanich G. P. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally. Neurobiol. Learning Mem. 69:1998;225-240.
6. Fader A. J., Johnson P. E. M., Dohanich G. P. Estrogen improves working but not reference memory and prevents amnestic effects of scopolamine on a radial-arm maze. Pharmacol. Biochem. Behav. 62:1999;711-717.
7. Gibbs R. B. Estrogen and nerve growth factor-related systems in brain: Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Luine V. N., Harding C. F. Hormonal Restructuring of the Adult Brain: Basic and Clinical Perspectives. 1994;165-199 New York Acad. Sci. New York.
8. Gibbs R. B. Expression of estrogen receptor-like immunoreactivity by different subgroups of basal forebrain cholinergic neurons in gonadectomized male and female rats. Brain Res. 720:1996a;61-68.
9. Gibbs R. B. Fluctuations in relative levels of choline acetyltransferase mRNA in different regions of the rat basal forebrain across the estrous cycle: Effects of estrogen and progesterone. J. Neurosci. 16:1996b;1049-1055.
10. Gibbs R. B. Effects of estrogen on basal forebrain cholinergic neurons vary as a function of dose and duration of treatment. Brain Res. 757:1997;10-16.
11. Gibbs R. B. Impairment of basal forebrain cholinergic neurons associated with aging and long-term loss of ovarian function. Exp. Neurol. 151:1998a;289-302.
12. Gibbs R. B. Levels of trkA and BDNF mRNA, but not NGF mRNA, fluctuate across the estrous cycle and increase in response to acute hormone replacement. Brain Res. 787:1998b;259-268.
13. Gibbs R. B., Aggarwal P. Estrogen and basal forebrain cholinergic neurons: Implications for brain aging and Alzheimer's disease-related cognitive decline. Horm. Behav. 34:1998;98-111.
14. Gibbs R. B., Hashash A., Johnson D. A. Effects of estrogen on potassium-evoked acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res. 749:1997;143-146.
15. NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp. Neurol. 116:1992;23-39.
16. Gibbs R. B., Wu D.-H., Hersh L., Pfaff D. W. Effects of estrogen replacement on relative levels of ChAT, TrkA and nerve growth factor messenger RNAs in the basal forebrain and hippocampal formation of adult rats. Exp. Neurol. 129:1994;70-80.
17. Henderson V. W., Watt L., Buckwalter J. G. Cognitive skills associated with estrogen replacement in women with Alzheimer's disease. Psychoneuroendocrinology. 21:1996;421-430.
18. Honjo H., Tanaka K., Kashiwagi T., Urabe M., Hayashi O. M., Hayashi K. Senile dementia-Alzheimer's type and estrogen. Horm. Metab. Res. 27:1995;204-207.
19. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D. L., Metter E. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology. 48:1997;1517-1521.
20. Luine V., Rodriguez M. Effects of estradiol on radial arm maze performance of young and aged rats. Behav. Neural Biol. 62:1994;230-236.
21. Luine V. N. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89:1985;484-490.
22. Luine V. N. Steroid hormone modulation of hippocampal dependent spatial memory. Stress. 2:1997;21-36.
23. McMillan P. J., Singer C. A., Dorsa D. M. The effects of ovariectomy and estrogen replacement on trkA and choline acetyltransferase mRNA expression in the basal forebrain of adult female Sprague-Dawley rat. J. Neurosci. 16:1996;1860-1865.
24. Miranda P., Williams C. L., Einstein G. Granule cells in aging rats are sexually dimorphic in their response to estradiol. J. Neurosci. 19:1999;3316-3325.
25. Muir J. L., Page K. J., Sirinathsinghji D. J., Robbins T. W., Everitt B. J. Excitotoxic lesions of basal forebrain cholinergic neurons effects on learning, memory and attention. Behav. Brain Res. 57:1993;123-131.
26. Murphy D. D., Cole N. B., Greenberger V., Segal M. Estradiol increases dendritic spine density by reducing GABA neurotransmission in hippocampal neurons. J. Neurosci. 18:1998;2550-2559.
27. Murphy D. D., Segal M. Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones. J. Neurosci. 16:1996;4059-4068.
28. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr. J. 41:1994;361-371.
29. Ohkura T., Isse K., Akazawa K., Hamamoto M., Yaoi Y., Hagino N. Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports. Dementia. 6:1995;99-107.
30. Ohta H., Ni X. H., Matsumoto K., Watanabe H. Working memory deficit in aged rats in delayed nonmatching to position task and effect of physostigmine on performance of young and aged rats. Japan J. Pharmacol. 56:1991;303-309.
31. O'Malley C. A., Hautamaki R. D., Kelley M., Meyer E. M. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ACh synthesis, and release from rat cerebral cortical synaptosomes. Brain Res. 403:1987;389-392.
32. Paganini-Hill A., Henderson V. W. Estrogen replacement therapy and risk of Alzheimer's disease. Arch. Intern. Med. 156:1996;2213-2217.
33. Schneider L. S., Farlow M. R., Henderson V. W., Pogoda J. M. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease. Neurology. 46:1996;1580-1584.
34. Sherwin B. B. Estrogen and cognitive functioning in women. Proc. Soc. Exp. Biol. Med. 217:1998;17-22.
35. Singer C. A., McMillan P. J., Dobie D. J., Dorsa D. M. Effects of estrogen replacement on choline acetyltransferase and trkA mRNA expression in the basal forebrain of aged rats. Brain Res. 789:1998;343-346.
36. Singh M., Meyer E. M., Huang F. S., Millard W. J., Simpkins J. W. Ovariectomy reduces ChAT activity and NGF mRNA levels in the frontal cortex and hippocampus of the female Sprague Dawley rat. Program of the 23rd Annual Meeting of the Society for Neuroscience. 1993;. p. 1254.
37. Singh M., Meyer E. M., Millard W. J., Simpkins J. W. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
38. Tang M.-X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. The Lancet. 348:1996;429-432.
39. Wenk G. L. The nucleus basalis magnocellularis cholinergic system: One hundred years of progress. Neurobiol. Learning Mem. 67:1997;85-95.
40. Woolf N. J. Cholinergic systems in mammalian brain and spinal cord. Prog. Neurobiol. 37:1991;475-524.
41. Woolley C. S., McEwen B. S. Estradiol regulates hippocampal dendritic spine density via an N-methyl-D-aspartate receptor-dependent mechanism. J. Neurosci. 14:1994;7680-7687.
42. Woolley C. S., Weiland N. G., McEwen B. S., Schwartzkroin P. A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density. J. Neurosci. 17:1997;1848-1859.
43. Woolley C. S., Wenzel H. J., Schwartzkroin P. A. Estradiol increases the frequency of multiple synaptic boutons in the hippocampal CA1 region of the adult female rat. J. Comp. Neurol. 373:1996;108-117.